Physicians prescribing SGLT2 inhibitors, a newer class of diabetes drugs, are advised to “have a high index of suspicion” about the potentially fatal complication.
Medscape Medical News …read more
Physicians prescribing SGLT2 inhibitors, a newer class of diabetes drugs, are advised to “have a high index of suspicion” about the potentially fatal complication.
Medscape Medical News …read more